Based on the Chromocell Therapeutics Corporation stock forecast from 1 analysts, the average analyst target price for Chromocell Therapeutics Corporation is USD 8.50 over the next 12 months. Chromocell Therapeutics Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Chromocell Therapeutics Corporation is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Chromocell Therapeutics Corporation’s stock price was USD 0.64. Chromocell Therapeutics Corporation’s stock price has changed by +0.30% over the past week, -2.89% over the past month and 0% over the last year.
No recent analyst target price found for Chromocell Therapeutics Corporation
No recent average analyst rating found for Chromocell Therapeutics Corporation
Company Overview Chromocell Therapeutics Corporation
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Chromocell Therapeutics Corporation (CHRO)
Loading...
Unadjusted Closing Price for Chromocell Therapeutics Corporation (CHRO)
Loading...
Share Trading Volume for Chromocell Therapeutics Corporation Shares
Loading...
Compare Performance of Chromocell Therapeutics Corporation Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for CHRO
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Chromocell Therapeutics Corporation (Sector: Other )
Frequently Asked Questions About Chromocell Therapeutics Corporation (CHRO) Stock
Based on ratings from 1 analysts Chromocell Therapeutics Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on CHRO's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for CHRO is USD 8.50 over the next 12 months. The maximum analyst target price is USD 8.5 while the minimum anlayst target price is USD 8.5.
Unfortunately we do not have enough data on CHRO's stock to indicate if its overvalued.
The last closing price of CHRO's stock was USD 0.64.
Unfortunately we do not currently have any market capitalization data for CHRO's stock.
Based on targets from 1 analysts, the average taret price for CHRO is projected at USD 8.50 over the next 12 months.
This means that CHRO's stock price may go up by +1,224.19% over the next 12 months.
We can't find any ETFs which contains Chromocell Therapeutics Corporation's stock.
Sorry, we do not have any data on the number of employees for Chromocell Therapeutics Corporation.
Sorry we do not have any infomation available on Chromocell Therapeutics Corporation's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
There is nothing we particularly dislike
Frequently Asked Questions About Chromocell Therapeutics Corporation (CHRO) Stock
Based on ratings from 1 analysts Chromocell Therapeutics Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on CHRO's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for CHRO is USD 8.50 over the next 12 months. The maximum analyst target price is USD 8.5 while the minimum anlayst target price is USD 8.5.
Unfortunately we do not have enough data on CHRO's stock to indicate if its overvalued.
The last closing price of CHRO's stock was USD 0.64.
Unfortunately we do not currently have any market capitalization data for CHRO's stock.
Based on targets from 1 analysts, the average taret price for CHRO is projected at USD 8.50 over the next 12 months.
This means that CHRO's stock price may go up by +1,224.19% over the next 12 months.
We can't find any ETFs which contains Chromocell Therapeutics Corporation's stock.
Sorry, we do not have any data on the number of employees for Chromocell Therapeutics Corporation.
Sorry we do not have any infomation available on Chromocell Therapeutics Corporation's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CHRO !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
